EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Endoscopic sclerotherapy of bleeding esophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis



Endoscopic sclerotherapy of bleeding esophageal varices. A comparative study of results in patients with schistosomiasis and cirrhosis



Endoscopy 20(4): 134-136



Endoscopic sclerotherapy for bleeding esophageal varices was carried out in 78 patients with schistosomiasis (Group I) and 71 cirrhotic patients (Group II). All Group I patients had uniformly good liver function. According to Child's classification 25 patients (35%) of Group II were Child A, 16 (23%) Child B and 30 (42%) Child C. The sclerotherapy was performed by intravascular injections of 3% ethanolamine. Throughout a follow-up period of at least 24 months, hemorrhage recurred in 13% of the Group I patients, with one death (1%). The Child A category had a 24% recurrence with a 4% death rate, Child B a 38% recurrence with a 50% death rate, and Child C group a 73% recurrence with no survivals. A comparison of patients with schistosomiasis and cirrhosis type A revealed no differences with respect to rebleeding or survival (p greater than 0.05). Differences were significant for bleeding recurrence and survival in Child B patients as compared with schistosomiasis patients (p less than 0.025). This difference was highly remarkable when patients with schistosomiasis were compared with Child C cases, both for recurrence and survival (p less than 0.001). On the basis of these observations it is concluded that results of sclerotherapy depend fundamentally on liver function, and thus this procedure is justified in the early phases of liver cirrhosis.

(PDF emailed within 0-6 h: $19.90)

Accession: 005359576

Download citation: RISBibTeXText

PMID: 3263266

DOI: 10.1055/s-2007-1018157



Related references

Sclerotherapy of bleeding esophageal varices in schistosomiasis. Comparative study in patients with and without previous surgery for portal hypertension. Endoscopy 22(1): 5-7, 1990

Efficacy of endoscopic sclerotherapy on long term management of esophageal varices a comparative study of results in patients with cirrhosis of the liver non cirrhotic portal fibrosis ncpf and extrahepatic portal venous obstruction eho. Journal of Gastroenterology & Hepatology 6(5): 471-475, 1991

Endoscopic sclerotherapy versus propranolol after hemorrhage caused by rupture of esophageal varices in patients with cirrhosis. Results of a 4-year randomized study. Gastroenterologie Clinique et Biologique 12(3): 234-239, 1988

Optimized analysis of recurrent bleeding and death in patients with cirrhosis and esophageal varices. Copenhagen Esophageal Varices Sclerotherapy Project. Journal of Hepatology 21(3): 367-375, 1994

Survival in hepatitis-B cirrhosis compared to alcoholic cirrhosis in patients with Child's C liver disease: a prospective study of endoscopic sclerotherapy for bleeding oesophageal varices. Singapore Medical Journal 35(1): 53-56, 1994

Analysis of the treatment effect on recurrent bleeding and death in patients with cirrhosis and esophageal varices: multistage competing-risks model compared to conventional methods. The Copenhagen Esophageal Varices Sclerotherapy Project. Journal of Hepatology 28(1): 107-114, 1998

Who benefits from endoscopic sclerotherapy of bleeding oesophageal varices? Proposal for differential indications. The Copenhagen Esophageal Varices Sclerotherapy Project. Journal of Hepatology 15(1-2): 184-191, 1992

Clinical evaluation of endoscopic injection sclerotherapy for bleeding esophageal varices in liver cirrhosis with hepatocellular carcinoma. Gastroenterologia Japonica 26 Suppl 3: 36-38, 1991

Endoscopic sclerotherapy of bleeding esophageal varices results and complications. Tidsskrift for den Norske Laegeforening 106(16): 1390-1391, 1421, 1986

Emergency endoscopic sclerotherapy for bleeding esophageal varices: a prospective study in patients not responding to balloon tamponade. Gastrointestinal Endoscopy 29(1): 8-14, 1983

Scintigraphic study of gastric emptying after endoscopic sclerotherapy of esophageal varices in patients with alcoholic liver cirrhosis. Gastroenterologie Clinique et Biologique 16(10): 812-812, 1992

Emergency sclerotherapy for bleeding oesophageal varices in patients with hepatic schistosomiasis and/or non-alcoholic cirrhosis. Journal of Tropical Medicine 2(2): 1-6, 1992

The course of patients after obliteration of bleeding esophageal varices by sclerotherapy results of a prospective study. Journal of Hepatology 3: S55, 1986

Clinical analysis of early esophageal varices bleeding after endoscopic varices ligation in advanced schistosomiasis patients. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi 26(5): 577-578, 2015

Portal venous system after endoscopic sclerotherapy of esophageal varices in patients with liver cirrhosis--prospective study with Doppler sonography. Hepato-Gastroenterology 52(65): 1448-1451, 2005